Results of men with intermediate-risk prostate cancer who had received long-term hormonal therapy after radiation therapy were examined by a secondary analysis of the historic RTOG 9202 prostate cancer trial. It concluded that there were no additional benefits when compared to short-term hormonal therapy. The research was presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. Men with advanced prostate cancer typically receive hormonal ...Wednesday, 2 October 2013
Overall Survival Doesn't Improve On Use Of Long-term Hormonal Therapy in Intermediate-risk PCa Patients
Results of men with intermediate-risk prostate cancer who had received long-term hormonal therapy after radiation therapy were examined by a secondary analysis of the historic RTOG 9202 prostate cancer trial. It concluded that there were no additional benefits when compared to short-term hormonal therapy. The research was presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. Men with advanced prostate cancer typically receive hormonal ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment